FDA Concluded Investigation into Formula Botulism Outbreak
Fifty infants were hospitalized in a botulism outbreak linked to formula brands ByHeart and Nara.
Updated on Oct. 5, 2026 in Babies
Live Poll
Should federal regulators mandate stricter botulism testing for all infant formula manufacturers?
The FDA has finished its investigation into a botulism outbreak that resulted in the hospitalization of 50 babies. The agency traced contaminated ingredients back to 22 separate dairies across the country.
Why it matters
The investigation highlights critical gaps in infant formula safety, as current regulations do not require industry-wide testing for botulism. These findings have prompted Congress to consider legislation that would mandate routine testing protocols for all formula manufacturers.
The FDA identified 22 dairies as the source of contaminated milk ingredients linked to 50 infant hospitalizations. While botulism reports associated with formula have appeared in databases over the last 20 years, no industry-wide mandate for routine powdered formula testing currently exists.
The players
FDA
The federal agency responsible for protecting public health by ensuring the safety and security of food, including infant formula.
ByHeart
An infant formula manufacturer that reported limited oversight of dairy suppliers involved in the contamination.
Nara
An infant formula brand implicated in the botulism outbreak.
The details
Investigators tracked the milk supply chain to pinpoint the 22 dairies responsible for the contamination. ByHeart noted it lacked direct control or visibility over the specific farms chosen by its suppliers, leading manufacturers to now switch milk sources and develop new internal testing protocols. The process of testing powdered formula remains complex, as botulism spores can be difficult to detect within the large-scale production environments used by the industry.
Timeline
Three years ago, the first infection in the outbreak occurred.
In 2023, the FDA issued a warning to the infant formula industry regarding botulism.
In 2001, Kevin Kowalcyk died from E. coli.
Health Landscape
This outbreak highlights the long-standing regulatory challenges in the infant nutrition market, which has historically functioned without mandatory botulism screening. Congress is now evaluating legislation that would update safety requirements to exceed the standards established by current federal oversight.
Parents concerned about product safety should monitor official recall databases and discuss any specific feeding questions with their pediatrician. While manufacturers are updating testing protocols, caregivers should reach out to their physician if they note unusual symptoms in their child.
The takeaway
The FDA investigation confirms that infant formula safety relies heavily on supplier transparency and proactive testing. Caregivers should stay informed on food safety alerts and consult their pediatrician regarding any concerns about the products used for infant nutrition.
Further reading
For more on keeping infants safe, visit the Babies section.
Source note: This article includes information reported by The National Desk.
Live Poll
Should federal regulators mandate stricter botulism testing for all infant formula manufacturers?
